Dr. Ryll has been an extremely active member of the EU Cancer Mision Board, and a pioneer in how good patient-researcher partnerships can boost the quality of research and the impact of its results. 

This lecture is part of the "Champalimaud Cancer Talks" series, organised by the Champalimaud Foundation with the aim of offering the general public unique opportunities to hear the world's leading authorities in different fields related to cancer research and clinical practice. This time, Professor Hidde Ploegh will present his research work on: